This 18-amino acid peptide binds the SARS-CoV-2 RBD at key residues (Leu455, Phe456, Ala475, Gln493), inhibiting viral entry. It serves as a valuable research tool for in vitro studies of spike protein interactions and the development of antiviral entry inhibitors.